发明名称 HCV-HEMMENDE SULFONAMIDE
摘要 The present invention concerns sulfonamide derivatives having the general formula and N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs and esters thereof, wherein Q<SUB>1 </SUB>is -S- or -O-; R<SUB>1 </SUB>is hydrogen, C<SUB>1-6</SUB>alkyl, hydroxy, amino, halogen, aminoC<SUB>1-4</SUB>alkyl and mono- or di(C<SUB>1-4</SUB>alkyl)amino; R<SUB>2 </SUB>is hydrogen or C<SUB>1-6</SUB>alkyl; R<SUB>3 </SUB>is C<SUB>1-6</SUB>alkyl, aryl, C<SUB>3-7</SUB>cycloalkyl, C<SUB>3-7</SUB>cycloalkylC<SUB>1-4</SUB>alkyl, or arylC<SUB>1-4</SUB>alkyl; R<SUB>4 </SUB>is hydrogen, C<SUB>1-4</SUB>alkyloxycarbonyl, carboxyl, optionally mono- or disubstituted aminocarbonyl, mono- or di(C<SUB>1-4</SUB>alkyl)aminocarbonyl, C<SUB>3-7</SUB>cycloalkyl, C<SUB>2-6</SUB>alkenyl, C<SUB>2-6</SUB>alkynyl or C<SUB>1-6</SUB>alkyl optionally substituted with one or more substituents each independently selected from aryl, Het<SUP>1</SUP>, Het<SUP>2</SUP>, C<SUB>3-7</SUB>cycloalkyl, C<SUB>1-4</SUB>alkyloxy-carbonyl, carboxyl, aminocarbonyl, mono- or di(C<SUB>1-4</SUB>alkyl)aminocarbonyl, aminosulfonyl, C<SUB>1-4</SUB>alkylS(-O)<SUB>t</SUB>, hydroxy, cyano, halogen or amino optionally mono- or di-substituted where the substituents are each independently selected from C<SUB>1-4</SUB>alkyl, aryl, arylC<SUB>1-4</SUB>alkyl, C<SUB>3-7</SUB>cycloalkyl, C<SUB>3-7</SUB>cycloalkylC<SUB>1-4</SUB>alkyl, Het<SUP>1</SUP>, Het<SUP>2</SUP>, Het<SUP>1</SUP>C<SUB>1-4</SUB>alkyl and Het<SUP>2</SUP>C<SUB>1-4</SUB>alkyl; Q<SUB>2 </SUB>is a radical of formula for the manufacture of a medicament useful for inhibiting HCV activity in a mammal infected with HCV. The present invention also relates to the use of said sulfonamides in pharmaceutical compositions aimed to treat or combat combined HCV and HIV infections. In addition, the present invention relates to processes for preparation of such pharmaceutical compositions. The present invention also concerns combinations of the present sulfonamides with other anti-HCV agents and/or anti-HIV agents.
申请公布号 DE602004010291(D1) 申请公布日期 2008.01.03
申请号 DE20046010291T 申请日期 2004.09.30
申请人 TIBOTEC PHARMACEUTICALS LTD. 发明人 SIMMEN, KENNETH ALAN;VAN ACKER, KOENRAAD LODEWIJK AUGUST;WIGERINCK, PIET TOM BERT PAUL;SURLERAUX, DOMINIQUE LOUIS NESTOR GHISLAIN;DAMS, GERY KAREL JULIA;QUIRYNEN, LUDO MARIA MARCEL;HERTOGS, KURT;PAUWELS, RUDI WILFRIED JAN
分类号 A61K31/18;A61K31/421;A61K31/426;A61K45/06;A61P31/14 主分类号 A61K31/18
代理机构 代理人
主权项
地址